FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joost Meijers

Research Profile

Chemicals & Drugs

Physiology

Living Beings

Mouse

Procedures

Disorders

Concepts & Ideas

Kinetics

Phenomena

Protein Binding

Co-author Network

Publications

TOP 3
Marcel Schouten; Cornelis van 't Veer; Edward M Conway; J Daan de Boer; Marcel Levi; Joost C M Meijers; Joris J T H Roelofs; Tom van der Poll
The lectin-like domain of thrombomodulin hampers host defence in pneumococcal pneumonia.
Maurits L van Montfoort; Barbara A Hutten; Mandy N Lauw; Joost C M Meijers; Saskia Middeldorp; Shabnam Solati; Femke Stephan; Gerard van Mierlo; Sacha Zeerleder
Circulating nucleosomes and neutrophil activation as risk factors for deep vein thrombosis.
Anne Q Reuwer; Reinier O Schlingemann; Brigitte M Sondermeijer; Suzanne Battjes; Peter H Bisschop; Joost C M Meijers; Danka J F Stuijver; Marcel Th B Twickler; Rogier van Zijderveld; Erik S Stroes
Microcirculation and atherothrombotic parameters in prolactinoma patients: a pilot study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joost Meijers (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marcel Schouten; Cornelis van 't Veer; Edward M Conway; J Daan de Boer; Marcel Levi; Joost C M Meijers; Joris J T H Roelofs; Tom van der Poll
The lectin-like domain of thrombomodulin hampers host defence in pneumococcal pneumonia.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2013;41(4):935-42.
2013: Maurits L van Montfoort; Barbara A Hutten; Mandy N Lauw; Joost C M Meijers; Saskia Middeldorp; Shabnam Solati; Femke Stephan; Gerard van Mierlo; Sacha Zeerleder
Circulating nucleosomes and neutrophil activation as risk factors for deep vein thrombosis.
Arteriosclerosis, thrombosis, and vascular biology 2013;33(1):147-51.
2012: Anne Q Reuwer; Reinier O Schlingemann; Brigitte M Sondermeijer; Suzanne Battjes; Peter H Bisschop; Joost C M Meijers; Danka J F Stuijver; Marcel Th B Twickler; Rogier van Zijderveld; Erik S Stroes
Microcirculation and atherothrombotic parameters in prolactinoma patients: a pilot study.
Pituitary 2012;15(4):472-81.
2012: Milena B Brito; Rui A Ferriani; Andréa A Garcia; Joost C M Meijers; Silvana M Quintana; Marcos F Silva de Sá; Carolina S Vieira
Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: a randomized controlled trial.
Thrombosis research 2012;130(3):355-60.
2012: Liesbeth M Kager; Marcel Levi; Joost C M Meijers; Joris J T H Roelofs; Cornelis Van't Veer; W Joost Wiersinga; Tom van der Poll
Endogenous tissue-type plasminogen activator impairs host defense during severe experimental Gram-negative sepsis (melioidosis)*.
Critical care medicine 2012;40(7):2168-75.
2012: Felix M Wensveen; HaciAli Yigittop; Alex M de Bruin; Ingrid A M Derks; Eric Eldering; Joost C M Meijers; Martijn A Nolte; Klaas P J M van Gisbergen; René A W van Lier
BH3-only protein Noxa regulates apoptosis in activated B cells and controls high-affinity antibody formation.
Blood 2012;119(6):1440-9.
2012: Femke van Herrewegen; Joost C M Meijers; Marjolein Peters; C Heleen van Ommen
Clinical practice: the bleeding child. Part II: disorders of secondary hemostasis and fibrinolysis.
European journal of pediatrics 2012;171(2):207-14.
2011: Chantal J N Verkleij; Roderick E de Bruijn; Victor E A Gerdes; Eelco W Meesters; Joost C M Meijers; Pauline F Marx
The hemostatic system in patients with type 2 diabetes with and without cardiovascular disease.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2011;17(6):E57-63.
2011: L M Kager; Marcel Levi; Joost C M Meijers; Joris J T H Roelofs; Cornelis Van't Veer; Willem Joost Wiersinga; Tom van der Poll
Plasminogen activator inhibitor type I contributes to protective immunity during experimental Gram-negative sepsis (melioidosis).
Journal of thrombosis and haemostasis : JTH 2011;9(10):2020-8.
2011: Mercedes Valls Serón; Tom Plug; Philip G de Groot; Heiko Herwald; J Arnoud Marquart; Pauline F Marx; Joost C M Meijers
Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B.
Thrombosis and haemostasis 2011;106(4):609-16.
2011: JS De Jong; Jan-Willem N Akkerman; Joost C M Meijers; Rienk Nieuwland; Hanno L Tan; Marcel M G J van Borren; Arie O Verkerk; Arthur A M Wilde; Olga M Zakhrabova-Zwiauer; Lukas R C Dekker
Activated human platelet products induce proarrhythmic effects in ventricular myocytes.
Journal of molecular and cellular cardiology 2011;51(3):347-56.
2011: Cetin Agar; Philip G de Groot; Bas de Laat; Heiko Herwald; Johannes Levels; Stephanie D D C Monk; Matthias Mörgelin; Rolf T Urbanus; Tom van der Poll; Gwendolyn van Os; Joost C M Meijers
β₂-glycoprotein I: a novel component of innate immunity.
Blood 2011;117(25):6939-47.
2011: Erfan Nur; Eduard J van Beers; Shuena Martina; Ivan Cuccovillo; Hans-Martin Otten; John-John B Schnog; Joost C M Meijers; Alberto Mantovani; D P M Brandjes; Barbara Bottazzi; Bart J Biemond
Plasma levels of pentraxin-3, an acute phase protein, are increased during sickle cell painful crisis.
Blood cells, molecules & diseases 2011;46(3):189-94.
2011: David J van Westerloo; Goda Choi; Ester C Löwenberg; Jasper Truijen; Alex F de Vos; Erik Endert; Joost C M Meijers; Lu Zhou; Manuel P F L Pereira; Karla C S Queiroz; Sander H Diks; Marcel Levi; Maikel Peppelenbosch; Tom van der Poll
Acute stress elicited by bungee jumping suppresses human innate immunity.
Molecular medicine (Cambridge, Mass.) 2011;17(3-4):180-8.
2011: Ton Lisman; Marco Platto; Joost C M Meijers; Elizabeth B Haagsma; Michele Colledan; Robert J Porte
The hemostatic status of pediatric recipients of adult liver grafts suggests that plasma levels of hemostatic proteins are not regulated by the liver.
Blood 2011;117(6):2070-2.
2011: Brigitte M Sondermeijer; Anke J Tijsen; Mieke D Trip; Suthesh Sivapalaratnam; Annemieke Bakker; Suzanne Battjes; Esther E Creemers; Maurice W J de Ronde; Amalia Halliani; Maayke G M Kok; Steffi Maiwald; Arnoud A Marquart; Joost C M Meijers; Perry Moerland; Ties A Mulders; Sara-Joan Pinto-Sietsma
Platelets in patients with premature coronary artery disease exhibit upregulation of miRNA340* and miRNA624*.
PloS one 2011;6(10):e25946.
2011: Tatjana M H Niers; Dick J Richel; Joost C M Meijers; Reinier O Schlingemann
Vascular endothelial growth factor in the circulation in cancer patients may not be a relevant biomarker.
PloS one 2011;6(5):e19873.
2011: Tim J Schuijt; Sukanya Narasimhan; Sirlei Daffre; Kathleen DePonte; Joppe Hovius; Cornelis Van't Veer; Tom van der Poll; Kamran Bakhtiari; Joost C M Meijers; Eric T Boder; Alje P Van Dam; Erol Fikrig
Identification and characterization of Ixodes scapularis antigens that elicit tick immunity using yeast surface display.
PloS one 2011;6(1):e15926.
2011: Michael W T Tanck; Iris M Wichers; Joost C M Meijers; Harry R Büller; Pieter H Reitsma; Saskia Middeldorp
Quantitative trait locus for protein C in a family with thrombophilia.
Thrombosis and haemostasis 2011;105(1):199-201.
2010: Hong Zhang; Ester C Löwenberg; Jeffrey R Crosby; A Robert MacLeod; Chenguang Zhao; Dacao Gao; Chris Black; Alexey S Revenko; Joost C M Meijers; Erik S Stroes; Marcel Levi; Brett P Monia
Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk.
Blood 2010;116(22):4684-92.
2010: Chantal J N Verkleij; Joris J T H Roelofs; Stefan R Havik; Joost C M Meijers; Pauline F Marx
The role of thrombin-activatable fibrinolysis inhibitor in diabetic wound healing.
Thrombosis research 2010;126(5):442-6.
2010: Cetin Agar; Gwendolyn M A van Os; Matthias Mörgelin; Richard R Sprenger; J Arnoud Marquart; Rolf T Urbanus; R H W M Derksen; Joost C M Meijers; Philip G de Groot
Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome.
Blood 2010;116(8):1336-43.
2010: Mirjam E Meltzer; Ton Lisman; Philip G de Groot; Joost C M Meijers; Saskia Le Cessie; C J M Doggen; Frits R Rosendaal
Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1.
Blood 2010;116(1):113-21.
2010: K Ruitenbeek; Joost C M Meijers; Jelle Adelmeijer; Herman G D Hendriks; Robert J Porte; Ton Lisman
Intact thrombomodulin-mediated regulation of fibrinolysis during and after liver transplantation, despite a profoundly defective thrombomodulin-mediated regulation of coagulation.
Journal of thrombosis and haemostasis : JTH 2010;8(7):1646-9.
2010: Coen Maas; Joost C M Meijers; J Arnoud Marquart; Kamran Bakhtiari; Cees Weeterings; Philip G de Groot; Rolf T Urbanus
Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(20):9083-7.
2010: A J M Schreijer; M F Hoylaerts; Joost C M Meijers; H R Lijnen; Saskia Middeldorp; Harry R Büller; Pieter H Reitsma; Frits R Rosendaal; suzanne cannegieter
Explanations for coagulation activation after air travel.
Journal of thrombosis and haemostasis : JTH 2010;8(5):971-8.
2010: W Joost Wiersinga; Liesbeth M Kager; Joppe W R Hovius; Gerritje J W van der Windt; Alex F de Vos; Joost C M Meijers; Joris J Roelofs; Arjen Dondorp; Marcel Levi; Nicholas P Day; Sharon J Peacock; Tom van der Poll
Urokinase receptor is necessary for bacterial defense against pneumonia-derived septic melioidosis by facilitating phagocytosis.
Journal of immunology (Baltimore, Md. : 1950) 2010;184(6):3079-86.
2010: Ton Lisman; Kamran Bakhtiari; Ilona T A Pereboom; Herman G D Hendriks; Joost C M Meijers; Robert J Porte
Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests.
Journal of hepatology 2010;52(3):355-61.
2010: Gerry T M Wagenaar; Pavel Uhrin; Klara Weipoltshammer; Marlene Almeder; Pieter S Hiemstra; Margarethe Geiger; Joost C M Meijers; Christian Schöfer
Expression patterns of protein C inhibitor in mouse development.
Journal of molecular histology 2010;41(1):27-37.
2010: Peter Kraft; Tobias Schwarz; Joost C M Meijers; Guido Stoll; Christoph Kleinschnitz
Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice are susceptible to intracerebral thrombosis and ischemic stroke.
PloS one 2010;5(7):e11658.
2010: Tom van der Poll; Joost C M Meijers
Systemic inflammatory response syndrome and compensatory anti-inflammatory response syndrome in sepsis.
Journal of innate immunity 2010;2(5):379-80.
2010: Ester C Löwenberg; Prakaykaew Charunwatthana; Sophie Cohen; Bert-Jan van den Born; Joost C M Meijers; Emran B Yunus; Mahtab U Hassan; Gofranul Hoque; Richard J Maude; Forradee Nuchsongsin; Marcel Levi; Arjen M Dondorp
Severe malaria is associated with a deficiency of von Willebrand factor cleaving protease, ADAMTS13.
Thrombosis and haemostasis 2010;103(1):181-7.
2010: Nadine S Gibson; Maaike Sohne; V E A Gerdes; Joost C M Meijers; Harry R Buller
Clinical usefulness of prothrombin fragment 1+2 in patients with suspected pulmonary embolism.
Thrombosis research 2010;125(1):97-9.
2009: Erik Malmström; Matthias Mörgelin; Martin Malmsten; Linda Johansson; Anna Norrby-Teglund; Oonagh Shannon; Artur Schmidtchen; Joost C M Meijers; Heiko Herwald
Protein C inhibitor--a novel antimicrobial agent.
PLoS pathogens 2009;5(12):e1000698.
2009: Eefje Jong; Susan Louw; Joost C M Meijers; Martijn D de Kruif; Hugo ten Cate; Harry R Büller; Jan Willem Mulder; Eric C M van Gorp
The hemostatic balance in HIV-infected patients with and without antiretroviral therapy: partial restoration with antiretroviral therapy.
AIDS patient care and STDs 2009;23(12):1001-7.
2009: Eduard J van Beers; Marianne C L Schaap; René Berckmans; Rienk Nieuwland; Augueste Sturk; Frederiek F van Doormaal; Joost C M Meijers; Bart J Biemond
Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease.
Haematologica 2009;94(11):1513-9.
2009: Mervyn D I Vergouwen; Kamran Bakhtiari; Nan van Geloven; Marinus Vermeulen; Y B W E M Roos; Joost C M Meijers
Reduced ADAMTS13 activity in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2009;29(10):1734-41.
2009: Chantal J N Verkleij; Max Nieuwdorp; V E A Gerdes; Matthias Mörgelin; Joost C M Meijers; Pauline F Marx
The effects of hyperglycaemia on thrombin-activatable fibrinolysis inhibitor.
Thrombosis and haemostasis 2009;102(3):460-8.
2009: Pauline F Marx; Chantal J N Verkleij; Mercedes Valls Seron; Joost C M Meijers
Recent developments in thrombin-activatable fibrinolysis inhibitor research.
Mini reviews in medicinal chemistry 2009;9(10):1165-73.
2009: Mervyn D I Vergouwen; Joost C M Meijers; Ronald B Geskus; Bert A Coert; Janneke Horn; Erik S G Stroes; Tom van der Poll; Marinus Vermeulen; Y B W E M Roos
Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2009;29(8):1444-53.
2009: Joost C M Meijers
Feedback controversy stops here.
Blood 2009;114(2):235.
2009: Marieke A D van Zoelen; Sandrine Florquin; Regina de Beer; Jennie M Pater; Marleen I Verstege; Joost C M Meijers; Tom van der Poll
Urokinase plasminogen activator receptor-deficient mice demonstrate reduced hyperoxia-induced lung injury.
The American journal of pathology 2009;174(6):2182-9.
2009: Mirjam E Meltzer; C J M Doggen; Philip G de Groot; Joost C M Meijers; Frits R Rosendaal; Ton Lisman
Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men.
Haematologica 2009;94(6):811-8.
2009: Marieke A D van Zoelen; Marcel Schouten; Alex F de Vos; Sandrine Florquin; Joost C M Meijers; Peter P Nawroth; Angelika Bierhaus; Tom van der Poll
The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(7):4349-56.
2009: Iris M Wichers; Michael W T Tanck; Joost C M Meijers; Ton Lisman; Pieter H Reitsma; Frits R Rosendaal; Harry R Büller; Saskia Middeldorp
Assessment of coagulation and fibrinolysis in families with unexplained thrombophilia.
Thrombosis and haemostasis 2009;101(3):465-70.
2009: Marieke A D van Zoelen; Huan Yang; Sandrine Florquin; Joost C M Meijers; Shizuo Akira; Bernd Arnold; Peter P Nawroth; Angelika Bierhaus; Kevin Tracey; Tom van der Poll
Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo.
Shock (Augusta, Ga.) 2009;31(3):280-4.
2009: Pauline F Marx; T Plug; Stefan R Havik; M Mörgelin; Joost C M Meijers
The activation peptide of thrombin-activatable fibrinolysis inhibitor: a role in activity and stability of the enzyme?
Journal of thrombosis and haemostasis : JTH 2009;7(3):445-52.
2009: Sander I van Leuven; Rakesh S Birjmohun; R Franssen; Radjesh J Bisoendial; Hanneke de Kort; Johannes Levels; R L Basser; Joost C M Meijers; J A Kuivenhoven; John J P Kastelein; Erik S G Stroes
ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humans.
Journal of thrombosis and haemostasis : JTH 2009;7(2):347-54.
2009: Ester C Löwenberg; Arne W J H Dielis; Joost C M Meijers; Hugo ten Cate; Marcel Levi
[Better understanding of blood coagulation in vivo].
Nederlands tijdschrift voor geneeskunde 2009;153(1-2):30-7.
2009: Sara H Bengtson; Caroline Sandén; Matthias Mörgelin; Pauline F Marx; Anders I Olin; L M Fredrik Leeb-Lundberg; Joost C M Meijers; Heiko Herwald
Activation of TAFI on the surface of Streptococcus pyogenes evokes inflammatory reactions by modulating the kallikrein/kinin system.
Journal of innate immunity 2009;1(1):18-28.
2008: Rakesh S Birjmohun; G Kees Hovingh; Erik S G Stroes; Jorit J Hofstra; Geesje M Dallinga-Thie; Joost C M Meijers; John J P Kastelein; Marcel Levi
Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema.
Clinical therapeutics 2008;30(12):2314-23.
2008: Pauline F Marx; T Harma C Brondijk; Tom Plug; Roland A Romijn; Wieger Hemrika; Joost C M Meijers; Eric G Huizinga
Crystal structures of TAFI elucidate the inactivation mechanism of activated TAFI: a novel mechanism for enzyme autoregulation.
Blood 2008;112(7):2803-9.
2008: Ida A J Giebelen; Masja Leendertse; Mark C Dessing; Joost C M Meijers; Marcel Levi; Christian Draing; Sonja Von Aulock; Tom van der Poll
Endogenous beta-adrenergic receptors inhibit lipopolysaccharide-induced pulmonary cytokine release and coagulation.
American journal of respiratory cell and molecular biology 2008;39(3):373-9.
2008: Michiel E Stegenga; Saskia N van der Crabben; Regje M E Blümer; Marcel Levi; Joost C M Meijers; Mireille J Serlie; Michael W T Tanck; Hans P Sauerwein; Tom van der Poll
Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia.
Blood 2008;112(1):82-9.
2008: A J M Schreijer; suzanne cannegieter; Marianna Caramella; Joost C M Meijers; Raymond T Krediet; Ries M Simons; Frits R Rosendaal
Fluid loss does not explain coagulation activation during air travel.
Thrombosis and haemostasis 2008;99(6):1053-9.
2008: Bert-Jan H van den Born; Niels V van der Hoeven; Evelyn Groot; Peter J Lenting; Joost C M Meijers; Marcel Levi; Gert A van Montfrans
Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension.
Hypertension 2008;51(4):862-6.
2008: Marieke A D van Zoelen; Sandrine Florquin; Joost C M Meijers; Regina de Beer; Alex F de Vos; Onno J de Boer; Tom van der Poll
Platelet-activating factor receptor contributes to host defense against Pseudomonas aeruginosa pneumonia but is not essential for the accompanying inflammatory and procoagulant response.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(5):3357-65.
2008: Thijs W H Pols; Roelof Ottenhoff; Mariska Vos; Johannes Levels; Paul H A Quax; Joost C M Meijers; Hans Pannekoek; Albert K Groen; Carlie J M de Vries
Nur77 modulates hepatic lipid metabolism through suppression of SREBP1c activity.
Biochemical and biophysical research communications 2008;366(4):910-6.
2008: Maria Nilsson; Sylwia Wasylik; Matthias Mörgelin; Anders I Olin; Joost C M Meijers; R H W M Derksen; Philip G de Groot; Heiko Herwald
The antibacterial activity of peptides derived from human beta-2 glycoprotein I is inhibited by protein H and M1 protein from Streptococcus pyogenes.
Molecular microbiology 2008;67(3):482-92.
2008: W Joost Wiersinga; Joost C M Meijers; Marcel Levi; Cornelis van 't Veer; N P Day; S J Peacock; Tom van der Poll
Activation of coagulation with concurrent impairment of anticoagulant mechanisms correlates with a poor outcome in severe melioidosis.
Journal of thrombosis and haemostasis : JTH 2008;6(1):32-9.
2008: K Hillmayer; Els Brouwers; F León-Tamariz; Joost C M Meijers; P F Marx; Paul J Declerck; Ann Gils
Development of sandwich-type ELISAs for the quantification of rat and murine thrombin activatable fibrinolysis inhibitor in plasma.
Journal of thrombosis and haemostasis : JTH 2008;6(1):132-8.
2007: Johannes Levels; Dasja Pajkrt; Marcus Schultz; Frans J Hoek; Arie Van Tol; Joost C M Meijers; Sander J H van Deventer
Alterations in lipoprotein homeostasis during human experimental endotoxemia and clinical sepsis.
Biochimica et biophysica acta 2007;1771(12):1429-38.
2007: kees boer; I A den Hollander; Joost C M Meijers; M Levi
Tissue factor-dependent blood coagulation is enhanced following delivery irrespective of the mode of delivery.
Journal of thrombosis and haemostasis : JTH 2007;5(12):2415-20.
2007: Lisa I Påhlman; Pauline F Marx; Matthias Mörgelin; Slawomir Lukomski; Joost C M Meijers; Heiko Herwald
Thrombin-activatable fibrinolysis inhibitor binds to Streptococcus pyogenes by interacting with collagen-like proteins A and B.
The Journal of biological chemistry 2007;282(34):24873-81.
2007: Suzanne Q van Veen; Joost C M Meijers; Marcel Levi; Thomas M van Gulik; Marja A Boermeester
Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
Shock (Augusta, Ga.) 2007;27(5):534-41.
2007: Rakesh S Birjmohun; Sander I van Leuven; Johannes Levels; Cornelis van 't Veer; Jan Albert Kuivenhoven; Joost C M Meijers; Marcel Levi; John J P Kastelein; Tom van der Poll; Erik S G Stroes
High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(5):1153-8.
2007: Radjesh J Bisoendial; John J P Kastelein; Stephan L M Peters; Johannes Levels; Rakesh S Birjmohun; Joris Rotmans; Daniel Hartman; Joost C M Meijers; Marcel Levi; Erik S G Stroes
Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects.
Journal of lipid research 2007;48(4):952-60.
2007: Martijn D de Kruif; Lucienne C Lemaire; Ida A J Giebelen; Marieke A D van Zoelen; Jennie M Pater; Petra S van den Pangaart; Angelique P Groot; Alex F de Vos; Peter J Elliott; Joost C M Meijers; Marcel Levi; Tom van der Poll
Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(3):1845-51.
2007: Anne-Cornélie J M de Pont; Jorrit-Jan H Hofstra; Derk R Pik; Joost C M Meijers; Marcus Schultz
Pharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration: a pilot study.
Critical care (London, England) 2007;11(5):R102.
2006: C J M Doggen; Frits R Rosendaal; Joost C M Meijers
Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII.
Blood 2006;108(13):4045-51.
2006: Marieke A D van Zoelen; Kamran Bakhtiari; Mark C Dessing; Cornelis Van't Veer; C Arnold Spek; Michael W T Tanck; Joost C M Meijers; Tom van der Poll
Ethyl pyruvate exerts combined anti-inflammatory and anticoagulant effects on human monocytic cells.
Thrombosis and haemostasis 2006;96(6):789-93.
2006: Tymen T Keller; Koenraad F van der Sluijs; Martijn D de Kruif; V E A Gerdes; Joost C M Meijers; Sandrine Florquin; Tom van der Poll; Eric C M van Gorp; D P M Brandjes; Harry R Büller; Marcel Levi
Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1.
Circulation research 2006;99(11):1261-9.
2006: Suzanne Q van Veen; C W Cheung; Joost C M Meijers; Thomas M van Gulik; Marja A Boermeester
Anticoagulant and anti-inflammatory effects after peritoneal lavage with antithrombin in experimental polymicrobial peritonitis.
Journal of thrombosis and haemostasis : JTH 2006;4(11):2343-51.
2006: Peter Dahlem; Albert P Bos; Jack J Haitsma; M J Schultz; E K Wolthuis; Joost C M Meijers; B Lachmann
Mechanical ventilation affects alveolar fibrinolysis in LPS-induced lung injury.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2006;28(5):992-8.
2006: David J van Westerloo; Ida A J Giebelen; Joost C M Meijers; Joost Daalhuisen; Alex F de Vos; Marcel Levi; Tom van der Poll
Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in rats.
Journal of thrombosis and haemostasis : JTH 2006;4(9):1997-2002.
2006: Anne-Cornélie J M de Pont; Catherine S C Bouman; Kamran Bakhtiari; Marianne C L Schaap; Rienk Nieuwland; Augueste Sturk; Barbara A Hutten; Evert de Jonge; Margreeth B Vroom; Joost C M Meijers; Harry R Büller
Predilution versus postdilution during continuous venovenous hemofiltration: a comparison of circuit thrombogenesis.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 2006;52(4):416-22.
2006: Anne-Cornélie J M de Pont; Kamran Bakhtiari; Barbara A Hutten; Evert de Jonge; George P Vlasuk; William E Rote; Marcel Levi; Harry R Büller; Joost C M Meijers
Endotoxaemia induces resistance to activated protein C in healthy humans.
British journal of haematology 2006;134(2):213-9.
2006: Rob J Dekker; Reinier A Boon; Mariska G Rondaij; Astrid Kragt; Oscar L Volger; Yvonne W Elderkamp; Joost C M Meijers; Jan Voorberg; Hans Pannekoek; Anton J G Horrevoets
KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium.
Blood 2006;107(11):4354-63.
2006: William D Toff; Chris I Jones; Isobel Ford; Robert J Pearse; Henry G Watson; Stephen J Watt; John A S Ross; David P Gradwell; Anthony J Batchelor; Keith Abrams; Joost C M Meijers; Alison H Goodall; Michael Greaves
Effect of hypobaric hypoxia, simulating conditions during long-haul air travel, on coagulation, fibrinolysis, platelet function, and endothelial activation.
JAMA : the journal of the American Medical Association 2006;295(19):2251-61.
2006: A J M Schreijer; suzanne cannegieter; Joost C M Meijers; Saskia Middeldorp; Harry R Büller; Frits R Rosendaal
Activation of coagulation system during air travel: a crossover study.
Lancet 2006;367(9513):832-8.
2006: Max Nieuwdorp; Timon W van Haeften; Mirella C L G Gouverneur; Hans L Mooij; Miriam H P van Lieshout; Marcel Levi; Joost C M Meijers; Frits Holleman; J B L Hoekstra; Hans Vink; John J P Kastelein; Erik S G Stroes
Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo.
Diabetes 2006;55(2):480-6.
2006: Catherine S C Bouman; Anne-Cornélie J M de Pont; Joost C M Meijers; Kamran Bakhtiari; Dorina Roem; Sacha Zeerleder; Gertjan Wolbink; Johanna C Korevaar; Marcel Levi; Evert de Jonge
The effects of continuous venovenous hemofiltration on coagulation activation.
Critical care (London, England) 2006;10(5):R150.
2006: Farhad Rezaee; Bruno Casetta; Johannes Levels; Dave Speijer; Joost C M Meijers
Proteomic analysis of high-density lipoprotein.
Proteomics 2006;6(2):721-30.
2006: Rogier M Bertina; Nico H van Tilburg; Frits Haverkate; Bonno N Bouma; Peter A von dem Borne; Joost C M Meijers; W Campbell; D Eaton; Dirk F Hendriks; Johan L Willemse
Discovery of thrombin activatable fibrinolysis inhibitor (TAFI).
Journal of thrombosis and haemostasis : JTH 2006;4(1):256-7.
2005: Rosemarijn Renckens; Joris J T H Roelofs; Simone A J ter Horst; Cornelis van 't Veer; Stefan R Havik; Sandrine Florquin; Gerry T M Wagenaar; Joost C M Meijers; Tom van der Poll
Absence of thrombin-activatable fibrinolysis inhibitor protects against sepsis-induced liver injury in mice.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(10):6764-71.
2005: Marcello Di Nisio; Nick R Bijsterveld; Joost C M Meijers; Marcel Levi; Harry R Büller; Ron J G Peters
Effects of clopidogrel on the rebound hypercoagulable state after heparin discontinuation in patients with acute coronary syndromes.
Journal of the American College of Cardiology 2005;46(8):1582-3.
2005: Anne-Cornélie J M de Pont; Kamran Bakhtiari; Barbara A Hutten; Evert de Jonge; Margreeth B Vroom; Joost C M Meijers; Harry R Büller; Marcel Levi
Recombinant human activated protein C resets thrombin generation in patients with severe sepsis - a case control study.
Critical care (London, England) 2005;9(5):R490-7.
2005: Philip G de Groot; Bianca C H Lutters; R H W M Derksen; Ton Lisman; Joost C M Meijers; Frits R Rosendaal
Lupus anticoagulants and the risk of a first episode of deep venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2005;3(9):1993-7.
2005: Dirkje W Sommeijer; René Van Oerle; Pieter H Reitsma; Janneke J Timmerman; Joost C M Meijers; Henri M H Spronk; Hugo ten Cate
Analysis of blood coagulation in mice: pre-analytical conditions and evaluation of a home-made assay for thrombin-antithrombin complexes.
Thrombosis journal 2005;3():12.
2005: Nico A Maris; Alex F de Vos; Paul Bresser; jaring s. van der zee; Joost C M Meijers; H Roger Lijnen; Marcel Levi; Henk M Jansen; Tom van der Poll
Activation of coagulation and inhibition of fibrinolysis in the lung after inhalation of lipopolysaccharide by healthy volunteers.
Thrombosis and haemostasis 2005;93(6):1036-40.
2005: Pauline F Marx; Stefan R Havik; Bonno N Bouma; Joost C M Meijers
Role of isoleucine residues 182 and 183 in thrombin-activatable fibrinolysis inhibitor.
Journal of thrombosis and haemostasis : JTH 2005;3(6):1293-300.
2005: Peter Dahlem; Albert P Bos; Jack J Haitsma; Marcus J Schultz; Joost C M Meijers; Burkhard Lachmann
Alveolar fibrinolytic capacity suppressed by injurious mechanical ventilation.
Intensive care medicine 2005;31(5):724-32.
2005: Radjesh J Bisoendial; John J P Kastelein; Johannes Levels; Jaap-Jan Zwaginga; Bas van den Bogaard; Pieter H Reitsma; Joost C M Meijers; Daniel Hartman; Marcel Levi; Erik S G Stroes
Activation of inflammation and coagulation after infusion of C-reactive protein in humans.
Circulation research 2005;96(7):714-6.
2005: Johannes Levels; J A Marquart; Philip Abraham; Abraham E van den Ende; H O F Molhuizen; Sander J H van Deventer; Joost C M Meijers
Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein.
Infection and immunity 2005;73(4):2321-6.
2005: Max Nieuwdorp; Erik S G Stroes; Joost C M Meijers; Harry Büller
Hypercoagulability in the metabolic syndrome.
Current opinion in pharmacology 2005;5(2):155-9.
2005: Ton Lisman; Philip G de Groot; Joost C M Meijers; Frits R Rosendaal
Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis.
Blood 2005;105(3):1102-5.
2004: Kamran Bakhtiari; Joost C M Meijers; Evert de Jonge; Marcel Levi
Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation.
Critical care medicine 2004;32(12):2416-21.
2004: Judith Gianotten; Alinda W M Schimmel; Fulco van der Veen; M Paola Lombardi; Joost C M Meijers
Absence of mutations in the PCI gene in subfertile men.
Molecular human reproduction 2004;10(11):807-13.
2004: Simone A J ter Horst; Gerry T M Wagenaar; Eveline de Boer; Margôt van Gastelen; Joost C M Meijers; Bart J Biemond; B J H M Poorthuis; Frans J Walther
Pentoxifylline reduces fibrin deposition and prolongs survival in neonatal hyperoxic lung injury.
Journal of applied physiology (Bethesda, Md. : 1985) 2004;97(5):2014-9.
2004: Dmitri V Kravtsov; Wenman Wu; Joost C M Meijers; Mao-Fu Sun; Morey A Blinder; Thao P Dang; Hongli Wang; David Gailani
Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain.
Blood 2004;104(1):128-34.
2004: JB Schnog; Melvin R Mac Gillavry; Anton P Van Zanten; Joost C M Meijers; RA Rojer; Ashley J Duits; Hugo ten Cate; D P M Brandjes
Protein C and S and inflammation in sickle cell disease.
American journal of hematology 2004;76(1):26-32.
2004: Arie Reijerkerk; Joost C M Meijers; Stefan R Havik; Bonno N Bouma; Emile E Voest; Martijn F B G Gebbink
Tumor growth and metastasis are not affected in thrombin-activatable fibrinolysis inhibitor-deficient mice.
Journal of thrombosis and haemostasis : JTH 2004;2(5):769-79.
2004: Pauline F Marx; Joost C M Meijers
Mechanism of action of carboxypeptidase U: staying above the threshold.
Journal of thrombosis and haemostasis : JTH 2004;2(3):414-5.
2004: Nick R Bijsterveld; Roel Vink; Benien E van Aken; Hein Fennema; Ron J G Peters; Joost C M Meijers; Harry R Büller; Marcel Levi
Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteers.
British journal of haematology 2004;124(5):653-8.
2004: Rosemarijn Renckens; Sebastiaan Weijer; Alex F de Vos; Jennie M Pater; Joost C M Meijers; C Erik Hack; Marcel Levi; Tom van der Poll
Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(3):483-8.
2004: Anita W Rijneveld; Sebastiaan Weijer; Sandrine Florquin; Charles T Esmon; Joost C M Meijers; Peter Speelman; Pieter H Reitsma; Hugo ten Cate; Tom van der Poll
Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide.
Blood 2004;103(5):1702-9.
2004: Pauline F Marx; Stefan R Havik; J Arnoud Marquart; Bonno N Bouma; Joost C M Meijers
Generation and characterization of a highly stable form of activated thrombin-activable fibrinolysis inhibitor.
The Journal of biological chemistry 2004;279(8):6620-8.
2004: Dirkje W Sommeijer; Melvin R MacGillavry; Joost C M Meijers; Anton P Van Zanten; Pieter H Reitsma; Hugo ten Cate
Anti-inflammatory and anticoagulant effects of pravastatin in patients with type 2 diabetes.
Diabetes care 2004;27(2):468-73.
2004: Jeanet M Kemmeren; Ale Algra; Joost C M Meijers; Guido Tans; Bonno N Bouma; Joyce Curvers; Jan Rosing; Diederick Grobbee
Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial.
Blood 2004;103(3):927-33.
2004: Bonno N Bouma; Joost C M Meijers
New insights into factors affecting clot stability: A role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxypeptidase B, plasma procarboxypeptidase U, procarboxypeptidase R).
Seminars in hematology 2004;41(1 Suppl 1):13-9.
2004: Anne-Cornélie J M de Pont; Arno H M Moons; Evert de Jonge; Joost C M Meijers; George P Vlasuk; William E Rote; Harry R Büller; Tom van der Poll; Marcel Levi
Recombinant nematode anticoagulant protein c2, an inhibitor of tissue factor/factor VIIa, attenuates coagulation and the interleukin-10 response in human endotoxemia.
Journal of thrombosis and haemostasis : JTH 2004;2(1):65-70.
2003: Ton Lisman; N R Bijsterveld; Jelle Adelmeijer; Joost C M Meijers; M Levi; H Karel Nieuwenhuis; Philip G de Groot
Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux.
Journal of thrombosis and haemostasis : JTH 2003;1(11):2368-73.
2003: Elisabeth A te Velde; G T M Wagenaar; Arie Reijerkerk; M Roose-Girma; Inne H M Borel Rinkes; Emile E Voest; Bonno N Bouma; Martijn F B G Gebbink; Joost C M Meijers
Impaired healing of cutaneous wounds and colonic anastomoses in mice lacking thrombin-activatable fibrinolysis inhibitor.
Journal of thrombosis and haemostasis : JTH 2003;1(10):2087-96.
2003: Nick R Bijsterveld; Arno H M Moons; Joost C M Meijers; Marcel Levi; Harry R Büller; Ron J G Peters
The impact on coagulation of an intravenous loading dose in addition to a subcutaneous regimen of low-molecular-weight heparin in the initial treatment of acute coronary syndromes.
Journal of the American College of Cardiology 2003;42(3):424-7.
2003: Bonno N Bouma; Joost C M Meijers
Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).
Journal of thrombosis and haemostasis : JTH 2003;1(7):1566-74.
2003: Laurent O Mosnier; Paula Buijtenhuijs; Pauline F Marx; Joost C M Meijers; Bonno N Bouma
Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platelets.
Blood 2003;101(12):4844-6.
2003: Arie Reijerkerk; Laurent O Mosnier; Onno Kranenburg; Bonno N Bouma; Peter Carmeliet; Tom A Drixler; Joost C M Meijers; Emile E Voest; Martijn F B G Gebbink
Amyloid endostatin induces endothelial cell detachment by stimulation of the plasminogen activation system.
Molecular cancer research : MCR 2003;1(8):561-8.
2003: Johannes Levels; Philip Abraham; Erik P van Barreveld; Joost C M Meijers; Sander J H van Deventer
Distribution and kinetics of lipoprotein-bound lipoteichoic acid.
Infection and immunity 2003;71(6):3280-4.
2003: Pieter H Reitsma; Judith Branger; Bernt van den Blink; Sebastiaan Weijer; Tom van der Poll; Joost C M Meijers
Procoagulant protein levels are differentially increased during human endotoxemia.
Journal of thrombosis and haemostasis : JTH 2003;1(5):1019-23.
2003: J Mathijs Vogten; Arie Reijerkerk; Joost C M Meijers; Emile E Voest; Inne H M Borel Rinkes; Martijn F B G Gebbink
The role of the fibrinolytic system in corneal angiogenesis.
Angiogenesis 2003;6(4):311-6.
2003: Annelies Verbon; Joost C M Meijers; C Arnold Spek; C Erik Hack; John P Pribble; Terence Turner; Pascale E P Dekkers; Tim Axtelle; Marcel Levi; Sander J H van Deventer; Pieter H Reitsma; Tom van der Poll
Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans.
The Journal of infectious diseases 2003;187(1):55-61.
2002: Nick R Bijsterveld; Arno H M Moons; S Matthijs Boekholdt; Benien E van Aken; Hein Fennema; Ron J G Peters; Joost C M Meijers; Harry R Büller; Marcel Levi
Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers.
Circulation 2002;106(20):2550-4.
2002: Marja Van Wijk; Kees Boer; René Berckmans; Joost C M Meijers; Joris A M van der Post; Augueste Sturk; Ed VanBavel; Rienk Nieuwland
Enhanced coagulation activation in preeclampsia: the role of APC resistance, microparticles and other plasma constituents.
Thrombosis and haemostasis 2002;88(3):415-20.
2002: JB Schnog; Melvin R Mac Gillavry; RA Rojer; Joost C M Meijers; R Fijnheer; Hugo ten Cate; D P M Brandjes; Ashley J Duits
No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell disease.
American journal of hematology 2002;71(1):53-5.
2002: Joost C M Meijers; J Arnoud Marquart; Rogier M Bertina; Bonno N Bouma; Frits R Rosendaal
Protein C inhibitor (plasminogen activator inhibitor-3) and the risk of venous thrombosis.
British journal of haematology 2002;118(2):604-9.
2002: Jeanet M Kemmeren; Ale Algra; Joost C M Meijers; Bonno N Bouma; Diederick Grobbee
Effect of second- and third-generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(5):373-81.
2002: Pauline F Marx; Philip E Dawson; Bonno N Bouma; Joost C M Meijers
Plasmin-mediated activation and inactivation of thrombin-activatable fibrinolysis inhibitor.
Biochemistry 2002;41(21):6688-96.
2002: Nick R Bijsterveld; Arno H M Moons; Joost C M Meijers; Jan G P Tijssen; Harry R Büller; Marcel Levi; Ron J G Peters
Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin.
Journal of the American College of Cardiology 2002;39(5):811-7.
2002: Thomas Renné; David Gailani; Joost C M Meijers; Werner Müller-Esterl
Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein.
The Journal of biological chemistry 2002;277(7):4892-9.
2002: Jeanet M Kemmeren; Ale Algra; Joost C M Meijers; Bonno N Bouma; Diederick Grobbee
Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Thrombosis and haemostasis 2002;87(2):199-205.
2002: Pauline F Marx; Bonno N Bouma; Joost C M Meijers
Role of zinc ions in activation and inactivation of thrombin-activatable fibrinolysis inhibitor.
Biochemistry 2002;41(4):1211-6.
2002: Ton Lisman; Laurent O Mosnier; Thierry Lambert; Eveline P Mauser-Bunschoten; Joost C M Meijers; H Karel Nieuwenhuis; Philip G de Groot
Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A.
Blood 2002;99(1):175-9.
2001: Laurent O Mosnier; MG Elisen; Bonno N Bouma; Joost C M Meijers
Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation.
Thrombosis and haemostasis 2001;86(4):1057-64.
2001: Laurent O Mosnier; Joost C M Meijers; Bonno N Bouma
The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis.
Thrombosis and haemostasis 2001;86(4):1040-6.
2001: Laurent O Mosnier; Ton Lisman; H Marijke van den Berg; H Karel Nieuwenhuis; Joost C M Meijers; Bonno N Bouma
The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration.
Thrombosis and haemostasis 2001;86(4):1035-9.
2001: Ton Lisman; Frank W G Leebeek; Laurent O Mosnier; Bonno N Bouma; Joost C M Meijers; Harry L A Janssen; H Karel Nieuwenhuis; Philip G de Groot
Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis.
Gastroenterology 2001;121(1):131-9.
2001: Marleen J A Simmelink; DA Horbach; R H W M Derksen; Joost C M Meijers; Edouard M Bevers; G M Willems; Philip G de Groot
Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces.
British journal of haematology 2001;113(3):621-9.
2001: RH van de Poel; Joost C M Meijers; Bonno N Bouma
C4b-binding protein inhibits the factor V-dependent but not the factor V-independent cofactor activity of protein S in the activated protein C-mediated inactivation of factor VIIIa.
Thrombosis and haemostasis 2001;85(5):761-5.
2001: Eric C M van Gorp; MC Minnema; Catharina Suharti; Albert T A Mairuhu; D P M Brandjes; Hugo ten Cate; C Erik Hack; Joost C M Meijers
Activation of coagulation factor XI, without detectable contact activation in dengue haemorrhagic fever.
British journal of haematology 2001;113(1):94-9.
2001: Bonno N Bouma; Pauline F Marx; Laurent O Mosnier; Joost C M Meijers
Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).
Thrombosis research 2001;101(5):329-54.
2001: Bianca C H Lutters; Joost C M Meijers; R H W M Derksen; Jef Arnout; Philip G de Groot
Dimers of beta 2-glycoprotein I mimic the in vitro effects of beta 2-glycoprotein I-anti-beta 2-glycoprotein I antibody complexes.
The Journal of biological chemistry 2001;276(5):3060-7.
2001: Laurent O Mosnier; Joost C M Meijers; Bonno N Bouma
Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin.
Thrombosis and haemostasis 2001;85(1):5-11.
2000: RH van de Poel; Joost C M Meijers; J Rosing; G Tans; Bonno N Bouma
C4b-binding protein protects coagulation factor Va from inactivation by activated protein C.
Biochemistry 2000;39(47):14543-8.
2000: Bonno N Bouma; Joost C M Meijers
Role of blood coagulation factor XI in downregulation of fibrinolysis.
Current opinion in hematology 2000;7(5):266-72.
2000: Guido Tans; Joyce Curvers; S Middeldorp; M Christella L G D Thomassen; Joost C M Meijers; Martin H Prins; Bonno N Bouma; Harry R Büller; Jan Rosing
A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
Thrombosis and haemostasis 2000;84(1):15-21.
2000: Joost C M Meijers; Saskia Middeldorp; Winnie L Tekelenburg; Abraham E van den Ende; Guido Tans; Martin H Prins; Jan Rosing; Harry R Büller; Bonno N Bouma
Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Thrombosis and haemostasis 2000;84(1):9-14.
2000: Saskia Middeldorp; Joost C M Meijers; Abraham E van den Ende; A van Enk; Bonno N Bouma; Guido Tans; Jan Rosing; Martin H Prins; Harry R Büller
Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
Thrombosis and haemostasis 2000;84(1):4-8.
2000: Pauline F Marx; Tilman M Hackeng; Philip E Dawson; J H Griffin; Joost C M Meijers; Bonno N Bouma
Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage.
The Journal of biological chemistry 2000;275(17):12410-5.
2000: Joost C M Meijers; Winnie L Tekelenburg; Bonno N Bouma; R M Bertina; F R Rosendaal
High levels of coagulation factor XI as a risk factor for venous thrombosis.
The New England journal of medicine 2000;342(10):696-701.
2000: Joost C M Meijers; Erik-Jan D Oudijk; Laurent O Mosnier; R Bos; Bonno N Bouma; H Karel Nieuwenhuis; Rob Fijnheer
Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia.
British journal of haematology 2000;108(3):518-23.
2000: RH van de Poel; Joost C M Meijers; Bonno N Bouma
The interaction between anticoagulant protein S and complement regulatory C4b-binding protein (C4BP).
Trends in cardiovascular medicine 2000;10(2):71-6.
2000: Pauline F Marx; G T M Wagenaar; Arie Reijerkerk; M J Tiekstra; A G van Rossum; Martijn F B G Gebbink; Joost C M Meijers
Characterization of mouse thrombin-activatable fibrinolysis inhibitor.
Thrombosis and haemostasis 2000;83(2):297-303.
2000: G T M Wagenaar; Anneke J van Vuuren; M Girma; M J Tiekstra; L Kwast; J G Koster; A W Rijneveld; MG Elisen; T van der Poll; Joost C M Meijers
Characterization of transgenic mice that secrete functional human protein C inhibitor into the circulation.
Thrombosis and haemostasis 2000;83(1):93-101.
1999: Jan Rosing; S Middeldorp; Joyce Curvers; M Christella; L G D Thomassen; Gerry A F Nicolaes; Joost C M Meijers; Bonno N Bouma; Harry R Büller; Martin H Prins; Guido Tans
Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
Lancet 1999;354(9195):2036-40.
1999: RH van de Poel; Joost C M Meijers; B Dahlbäck; Bonno N Bouma
C4b-binding protein (C4BP) beta-chain Short Consensus Repeat-2 specifically contributes to the interaction of C4BP with protein S.
Blood cells, molecules & diseases 1999;25(5-6):279-86.
1999: Thomas Renné; Jürgen Dedio; Joost C M Meijers; D Chung; Werner Müller-Esterl
Mapping of the discontinuous H-kininogen binding site of plasma prekallikrein. Evidence for a critical role of apple domain-2.
The Journal of biological chemistry 1999;274(36):25777-84.
1999: Bonno N Bouma; Joost C M Meijers
Fibrinolysis and the contact system: a role for factor XI in the down-regulation of fibrinolysis.
Thrombosis and haemostasis 1999;82(2):243-50.
1999: RH van de Poel; Joost C M Meijers; Bonno N Bouma
Interaction between protein S and complement C4b-binding protein (C4BP). Affinity studies using chimeras containing c4bp beta-chain short consensus repeats.
The Journal of biological chemistry 1999;274(21):15144-50.
1999: DA Horbach; Erica van Oort; Ton Lisman; Joost C M Meijers; R H W M Derksen; Philip G de Groot
Beta2-glycoprotein I is proteolytically cleaved in vivo upon activation of fibrinolysis.
Thrombosis and haemostasis 1999;81(1):87-95.
1998: M van Wijnen; Cornelis van 't Veer; Joost C M Meijers; R M Bertina; Bonno N Bouma
A plasma coagulation assay for an activated protein C-independent anticoagulant activity of protein S.
Thrombosis and haemostasis 1998;80(6):930-5.
1998: Laurent O Mosnier; Peter A von dem Borne; Joost C M Meijers; Bonno N Bouma
Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.
Thrombosis and haemostasis 1998;80(5):829-35.
1998: Bonno N Bouma; Peter A von dem Borne; Joost C M Meijers
Factor XI and protection of the fibrin clot against lysis--a role for the intrinsic pathway of coagulation in fibrinolysis.
Thrombosis and haemostasis 1998;80(1):24-7.
1998: MG Elisen; R J van Kooij; M A Nolte; J Arnoud Marquart; T M Lock; Bonno N Bouma; Joost C M Meijers
Protein C inhibitor may modulate human sperm-oocyte interactions.
Biology of reproduction 1998;58(3):670-7.
1998: MG Elisen; Peter A von dem Borne; Bonno N Bouma; Joost C M Meijers
Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma.
Blood 1998;91(5):1542-7.
1998: Marjolijn Bornebroek; Peter A von dem Borne; Joost Haan; Joost C M Meijers; William E Van Nostrand; R A Ross
Binding of amyloid beta precursor protein to coagulation factor XIa in vivo may favour haemorrhagic stroke.
Journal of neurology 1998;245(2):111-5.
1998: MC Minnema; Philip W Friederich; Marcel Levi; Peter A von dem Borne; Laurent O Mosnier; Joost C M Meijers; Bart J Biemond; C Erik Hack; Bonno N Bouma; Hugo ten Cate
Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor.
The Journal of clinical investigation 1998;101(1):10-4.
1997: Peter A von dem Borne; Laurent O Mosnier; G Tans; Joost C M Meijers; Bonno N Bouma
Factor XI activation by meizothrombin: stimulation by phospholipid vesicles containing both phosphatidylserine and phosphatidylethanolamine.
Thrombosis and haemostasis 1997;78(2):834-9.
1997: Peter A von dem Borne; Laszlo Bajzar; Joost C M Meijers; Michael E Nesheim; Bonno N Bouma
Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.
The Journal of clinical investigation 1997;99(10):2323-7.
1996: M van Wijnen; J G Stam; C van't Veer; Joost C M Meijers; P H Reitsma; R M Bertina; Bonno N Bouma
The interaction of protein S with the phospholipid surface is essential for the activated protein C-independent activity of protein S.
Thrombosis and haemostasis 1996;76(3):397-403.
1996: Peter A von dem Borne; Joost C M Meijers; Bonno N Bouma
Effect of heparin on the activation of factor XI by fibrin-bound thrombin.
Thrombosis and haemostasis 1996;76(3):347-53.
1996: MG Elisen; M H Maseland; Frank Church; Bonno N Bouma; Joost C M Meijers
Role of the A+ helix in heparin binding to protein C inhibitor.
Thrombosis and haemostasis 1996;75(5):760-6.
1996: A J Vlot; S J Koppelman; Joost C M Meijers; C Dama; H M van den Berg; Bonno N Bouma; Jan J Sixma; G M Willems
Kinetics of factor VIII-von Willebrand factor association.
Blood 1996;87(5):1809-16.
1995: Peter A von dem Borne; Joost C M Meijers; Bonno N Bouma
Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis.
Blood 1995;86(8):3035-42.
1995: W A Wuillemin; MC Minnema; Joost C M Meijers; D Roem; A J Eerenberg; J H Nuijens; Hugo ten Cate; C Erik Hack
Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitor.
Blood 1995;85(6):1517-26.
1994: R A Shirk; MG Elisen; Joost C M Meijers; Frank Church
Role of the H helix in heparin binding to protein C inhibitor.
The Journal of biological chemistry 1994;269(46):28690-5.
1994: Peter A von dem Borne; S J Koppelman; Bonno N Bouma; Joost C M Meijers
Surface independent factor XI activation by thrombin in the presence of high molecular weight kininogen.
Thrombosis and haemostasis 1994;72(3):397-402.
1994: T M Hackeng; C van 't Veer; Joost C M Meijers; Bonno N Bouma
Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa.
The Journal of biological chemistry 1994;269(33):21051-8.
1993: T M Hackeng; Martin Hessing; C van 't Veer; F Meijer-Huizinga; Joost C M Meijers; Philip G de Groot; J A van Mourik; Bonno N Bouma
Protein S binding to human endothelial cells is required for expression of cofactor activity for activated protein C.
The Journal of biological chemistry 1993;268(6):3993-4000.
1992: Joost C M Meijers; B A McMullen; Bonno N Bouma
The contact activation proteins: a structure/function overview.
Agents and actions. Supplements 1992;38 ( Pt 2)():219-30.
1989: J H Nuijens; C C Huijbregts; A J Eerenberg-Belmer; Joost C M Meijers; B N Bouma; C Erik Hack
Activation of the contact system of coagulation by a monoclonal antibody directed against a neodeterminant in the heavy chain region of human coagulation factor XII (Hageman factor).
The Journal of biological chemistry 1989;264(22):12941-9.
1989: F van Iwaarden; D S Acton; Jan J Sixma; Joost C M Meijers; Philip G de Groot; Bonno N Bouma
Internalization of antithrombin III by cultured human endothelial cells and its subcellular localization.
The Journal of laboratory and clinical medicine 1989;113(6):717-26.
1988: Joost A Koedam; Joost C M Meijers; Jan J Sixma; Bonno N Bouma
Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.
The Journal of clinical investigation 1988;82(4):1236-43.
1988: Joost C M Meijers; R A Vlooswijk; D H Kanters; Martin Hessing; Bonno N Bouma
Identification of monoclonal antibodies that inhibit the function of protein C inhibitor. Evidence for heparin-independent inhibition of activated protein C in plasma.
Blood 1988;72(4):1401-3.
1988: Joost C M Meijers; D H Kanters; R A Vlooswijk; H E van Erp; Martin Hessing; Bonno N Bouma
Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor.
Biochemistry 1988;27(12):4231-7.
1988: Joost C M Meijers; R A Vlooswijk; Bonno N Bouma
Inhibition of human blood coagulation factor XIa by C-1 inhibitor.
Biochemistry 1988;27(3):959-63.
1987: Joost C M Meijers; P N Tijburg; Bonno N Bouma
Inhibition of human blood coagulation factor Xa by alpha 2-macroglobulin.
Biochemistry 1987;26(18):5932-7.